DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Kondo M. et al.
Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRGTR03).
Breast cancer research and treatment 2011;
127: 739-749
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.